Snowden Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,492
| Closed | -$233K | – | 821 |
|
|
2020
Q4 | $233K | Buy |
+1,492
| New | +$233K | 0.02% | 592 |
|
|
2019
Q3 | – | Sell |
-1,820
| Closed | -$238K | – | 539 |
|
|
2019
Q2 | $238K | Buy |
+1,820
| New | +$238K | 0.02% | 453 |
|
|
2016
Q2 | – | Sell |
-7,909
| Closed | -$1.1M | – | 296 |
|
|
2016
Q1 | $1.1M | Buy |
+7,909
| New | +$1.1M | 0.38% | 96 |
|